HK Stock MarketDetailed Quotes

01858 CHUNLI MEDICAL

Watchlist
  • 11.580
  • -0.100-0.86%
Not Open May 3 16:09 CST
4.44BMarket Cap14.53P/E (TTM)

CHUNLI MEDICAL Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Cash flow from operating activities
Profit adjustment
Impairment and provisions:
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Revaluation surplus:
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Asset sale loss (gain):
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Depreciation and amortization:
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Operating profit before the change of operating capital
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Change of operating capital
Cash  from business operations
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Net cash from operations
-7.83%-129.61M
1,147.85%511.71M
118.00%13.75M
52.19%-38.97M
-497.38%-120.2M
-75.11%41.01M
-231.72%-76.37M
-530.17%-81.51M
-290.44%-20.12M
-36.79%164.79M
Cash flow from investment activities
Sale of fixed assets
--437.73K
-90.39%6.1K
----
----
----
43.78%63.5K
86.76%63.5K
86.76%63.5K
86.76%63.5K
-48.89%44.16K
Purchase of fixed assets
-1,215.97%-13.5M
-33.48%-33.24M
39.64%-34.6M
29.37%-19.14M
95.17%-1.03M
87.51%-24.9M
68.74%-57.32M
76.00%-27.1M
59.67%-21.23M
-730.70%-199.41M
Acquisition of subsidiaries
----
---6.99M
---6.99M
---3.69M
---9.6M
----
----
----
----
----
Recovery of cash from investments
8.67%831.3M
66.57%2.35B
-0.83%1.53B
65.67%1.52B
--765M
--1.41B
--1.54B
--920M
----
----
Cash on investment
2.50%-740M
-10.86%-2.41B
22.14%-1.58B
-11.99%-1.58B
-13.28%-759M
---2.17B
---2.03B
---1.41B
---670M
----
Other items in the investment business
-11.16%5.49M
-17.85%22.37M
11.79%13.75M
105.10%13.7M
635.26%6.18M
201.94%27.23M
82.17%12.3M
52.49%6.68M
-61.24%840.72K
278.60%9.02M
Net cash from investment operations
5,297.49%83.73M
89.31%-81.56M
84.76%-81.53M
87.47%-63.93M
100.22%1.55M
-300.64%-762.61M
-203.02%-534.95M
-370.44%-510.36M
-1,268.38%-690.33M
-783.83%-190.35M
Net cash before financing
61.33%-45.89M
159.61%430.16M
88.91%-67.79M
82.61%-102.91M
83.30%-118.65M
-2,723.04%-721.6M
-415.61%-611.32M
-561.04%-591.87M
-1,681.32%-710.45M
-110.69%-25.56M
Cash flow from financing activities
Dividends paid - financing
----
-140.32%-120.06M
-139.92%-120.06M
----
----
---49.96M
---50.04M
---36.94M
----
----
Absorb investment income
----
----
----
----
----
----
----
----
----
--1.08B
Other items of the financing business
----
85.93%-1.28M
91.78%-722.7K
88.93%-132.5K
---202.69K
-313.55%-9.08M
-421.72%-8.79M
6.34%-1.2M
----
---2.2M
Net cash from financing operations
--0
-105.53%-121.33M
-105.30%-120.78M
99.65%-132.5K
---202.69K
-105.50%-59.04M
-3,391.42%-58.83M
-2,884.11%-38.13M
--0
9,140.95%1.07B
Effect of rate
---4.21K
-100.31%-4.21K
-67.29%673.56K
86.11%673.56K
----
177.70%1.34M
411.30%2.06M
176.98%361.91K
-595.59%-218.02K
-29.53%-1.72M
Net Cash
61.39%-45.89M
139.63%308.82M
71.88%-187.89M
83.74%-102.37M
83.28%-118.85M
-174.48%-779.3M
-452.56%-668.09M
-589.76%-629.64M
-1,683.83%-710.67M
363.12%1.05B
Begining period cash
32.26%1.27B
-44.88%957.19M
-44.88%957.19M
-44.88%957.19M
-44.88%957.19M
151.62%1.74B
151.62%1.74B
151.62%1.74B
151.62%1.74B
48.68%690.12M
Cash at the end
45.54%1.22B
32.26%1.27B
-28.00%769.3M
-22.77%854.83M
-18.28%838.34M
-44.88%957.19M
87.70%1.07B
84.83%1.11B
57.75%1.03B
151.62%1.74B
Cash balance analysis
Cash and cash equivalent balance
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
Auditor
--
Daishin Certified Public Accountants (Special General Partnership)
--
--
--
Daishin Certified Public Accountants (Special General Partnership)
--
--
--
Daishin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Cash flow from operating activities
Profit adjustment
Impairment and provisions: --0--0--0--0--0--0--0--0--0--0
Revaluation surplus: --0--0--0--0--0--0--0--0--0--0
Asset sale loss (gain): --0--0--0--0--0--0--0--0--0--0
Depreciation and amortization: --0--0--0--0--0--0--0--0--0--0
Operating profit before the change of operating capital --0--0--0--0--0--0--0--0--0--0
Change of operating capital
Cash  from business operations --0--0--0--0--0--0--0--0--0--0
Net cash from operations -7.83%-129.61M1,147.85%511.71M118.00%13.75M52.19%-38.97M-497.38%-120.2M-75.11%41.01M-231.72%-76.37M-530.17%-81.51M-290.44%-20.12M-36.79%164.79M
Cash flow from investment activities
Sale of fixed assets --437.73K-90.39%6.1K------------43.78%63.5K86.76%63.5K86.76%63.5K86.76%63.5K-48.89%44.16K
Purchase of fixed assets -1,215.97%-13.5M-33.48%-33.24M39.64%-34.6M29.37%-19.14M95.17%-1.03M87.51%-24.9M68.74%-57.32M76.00%-27.1M59.67%-21.23M-730.70%-199.41M
Acquisition of subsidiaries -------6.99M---6.99M---3.69M---9.6M--------------------
Recovery of cash from investments 8.67%831.3M66.57%2.35B-0.83%1.53B65.67%1.52B--765M--1.41B--1.54B--920M--------
Cash on investment 2.50%-740M-10.86%-2.41B22.14%-1.58B-11.99%-1.58B-13.28%-759M---2.17B---2.03B---1.41B---670M----
Other items in the investment business -11.16%5.49M-17.85%22.37M11.79%13.75M105.10%13.7M635.26%6.18M201.94%27.23M82.17%12.3M52.49%6.68M-61.24%840.72K278.60%9.02M
Net cash from investment operations 5,297.49%83.73M89.31%-81.56M84.76%-81.53M87.47%-63.93M100.22%1.55M-300.64%-762.61M-203.02%-534.95M-370.44%-510.36M-1,268.38%-690.33M-783.83%-190.35M
Net cash before financing 61.33%-45.89M159.61%430.16M88.91%-67.79M82.61%-102.91M83.30%-118.65M-2,723.04%-721.6M-415.61%-611.32M-561.04%-591.87M-1,681.32%-710.45M-110.69%-25.56M
Cash flow from financing activities
Dividends paid - financing -----140.32%-120.06M-139.92%-120.06M-----------49.96M---50.04M---36.94M--------
Absorb investment income --------------------------------------1.08B
Other items of the financing business ----85.93%-1.28M91.78%-722.7K88.93%-132.5K---202.69K-313.55%-9.08M-421.72%-8.79M6.34%-1.2M-------2.2M
Net cash from financing operations --0-105.53%-121.33M-105.30%-120.78M99.65%-132.5K---202.69K-105.50%-59.04M-3,391.42%-58.83M-2,884.11%-38.13M--09,140.95%1.07B
Effect of rate ---4.21K-100.31%-4.21K-67.29%673.56K86.11%673.56K----177.70%1.34M411.30%2.06M176.98%361.91K-595.59%-218.02K-29.53%-1.72M
Net Cash 61.39%-45.89M139.63%308.82M71.88%-187.89M83.74%-102.37M83.28%-118.85M-174.48%-779.3M-452.56%-668.09M-589.76%-629.64M-1,683.83%-710.67M363.12%1.05B
Begining period cash 32.26%1.27B-44.88%957.19M-44.88%957.19M-44.88%957.19M-44.88%957.19M151.62%1.74B151.62%1.74B151.62%1.74B151.62%1.74B48.68%690.12M
Cash at the end 45.54%1.22B32.26%1.27B-28.00%769.3M-22.77%854.83M-18.28%838.34M-44.88%957.19M87.70%1.07B84.83%1.11B57.75%1.03B151.62%1.74B
Cash balance analysis
Cash and cash equivalent balance --0--0--0--0--0--0--0--0--0--0
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified Opinion------Unqualified Opinion------Unqualified Opinion
Auditor --Daishin Certified Public Accountants (Special General Partnership)------Daishin Certified Public Accountants (Special General Partnership)------Daishin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg